Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep-Oct;34(5):3039-3045.
doi: 10.21873/invivo.12138.

Preliminary Data of a Quantitative Point of Care Test for SARS-CoV-2 Antibodies From Greece

Affiliations

Preliminary Data of a Quantitative Point of Care Test for SARS-CoV-2 Antibodies From Greece

Paraskevi C Fragkou et al. In Vivo. 2020 Sep-Oct.

Abstract

Background: Antibody testing is necessary to identify immune individuals in the post-initial wave of the COVID-19 pandemic.

Patients and methods: We prospectively evaluated the performance of a quantitative point-of-care test (POCT) for SARS-CoV-2 antibodies. The patient group (PG) comprised of hospitalized confirmed COVID-19 cases. Asymptomatic healthcare volunteers with negative rRT-PCR were included in the control group (CG). Measurement of IgM and IgG was obtained by dry fluorescence immunoassay.

Results: Twenty-six PG (65.9±15.4 years old, male 57.7%) and 18 CG (45.6±10.1 years old, male 33.3%) were included. By manufacturer's cut-off (≥0.04 mIU/ml), sensitivity and specificity were 73.08% and 88.89% for IgM and 88.46% and 33.33% for IgG, respectively. Estimated areas under the ROC curve were 0.907 and 0.848 for IgM and IgG, respectively. Results were improved using a cut-off of IgM ≥0.05 mIU/ml and IgG ≥0.10 mIU/ml.

Conclusion: Using stringent cut-off values, SARS-CoV-2 antibody POCT detects immune people and can be used during socioeconomic normalization of communities.

Keywords: COVID-19; IgG; IgM; SARS-CoV-2; antibodies; diagnostics; novel coronavirus; point-of-care testing.

PubMed Disclaimer

Conflict of interest statement

The Authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Consumables, test strips and the reader were provided for free by Lansion Biotech.

Figures

Figure 1
Figure 1. Non-parametric ROC curves for IgM and IgG antibodies.
Figure 2
Figure 2. Quantitative analysis of anti-SARS-CoV-2 IgM and IgG antibodies by participant group [upper left, upper right] and by time of symptom onset [lower left, lower right]. Between participant groups differences [upper left, upper right]: p<0.001 for both IgM and IgG test. For time of symptom onset lower left, lower right]: p=0.083 for IgM, p=0.022 for IgG.

References

    1. COVID-19 situation reports. The World Health Organization. Available at: https://www.who.int/emergencies/diseases/novelcoronavirus-2019/situation... [Last accessed on 01 June 2020]
    1. Strategic preparedness and response plan for the novel coronavirus. The World Health Organization. Available at: https:// www.who.int/publications-detail/strategic-preparedness-andresponse-plan-... [Last accessed on 01 June 2020]
    1. Infection prevention and control. The World Health Organization. Available at: https://www.who.int/emergencies/diseases/novelcoronavirus-2019/technical... [Last accessed on 01 June 2020]
    1. COVID-19. European Centre for Disease Prevention and Control. Available at: https://www.ecdc.europa.eu/en/covid-19-pandemic [Last accessed on 01 June 2020] - PubMed
    1. Li D, Wang D, Dong J, Wang N, Huang H, Xu H, Xia C. False-negative results of real-time reverse-transcriptase polymerase chain reaction for severe acute respiratory syndrome coronavirus 2: Role of deep-learning-based CT diagnosis and insights from two cases. Korean J Radiol. 2020;21(4):505–508. doi: 10.3348/kjr.2020.0146. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources